Skip to main content
Signal8

Hallal David

SEC insider (Form 3/4/5 filer). CIK 0001457477. Chief Executive Officer at Scholar Rock Holding Corp (SRRK) and 2 other issuers. 18 reported Form 4/5 transactions since Sep 2024; latest on Sep 21, 2026. Located in CAMBRIDGE, MA.

Companies Hallal David has filed insider reports for

  • Scholar Rock Holding Corp (SRRK): Director, Officer, Chief Executive Officer
  • Kalaris Therapeutics, Inc. (KLRS): Director
  • iTeos Therapeutics, Inc. (ITOS): Director
Hallal David profile photo

Hallal David

CIK: 0001457477

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (27.8%)

Position reduction

Option Exercises (M)3 (16.7%)

Derivative conversions

Awards (A)6 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (22.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Scholar Rock Holding Corp logo
SRRK

Scholar Rock Holding Corp

DirectorOfficer
Kalaris Therapeutics, Inc. logo
KLRS

Kalaris Therapeutics, Inc.

Director
iTeos Therapeutics, Inc. logo
ITOS

iTeos Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (18 total)

  • Scholar Rock Holding Corp logo
    SRRK

    Scholar Rock Holding Corp

    Sep 21, 2026
    Gift
    Direct
    36.7K shares-
  • Kalaris Therapeutics, Inc. logo
    KLRS

    Kalaris Therapeutics, Inc.

    Jun 3, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    9K shares-
  • Scholar Rock Holding Corp logo
    SRRK

    Scholar Rock Holding Corp

    Apr 16, 2026
    Sale
    Direct
    30.6K shares at avg. $49.57$1.5M
  • Scholar Rock Holding Corp logo
    SRRK

    Scholar Rock Holding Corp

    Feb 9, 2026
    Award
    Direct
    128K shares-
  • Scholar Rock Holding Corp logo
    SRRK

    Scholar Rock Holding Corp

    Jan 13, 2026
    Sale
    Direct
    57.5K shares at avg. $42.70$2.5M
  • Scholar Rock Holding Corp logo
    SRRK

    Scholar Rock Holding Corp

    Oct 8, 2025
    Gift
    Direct
    205K shares-
  • iTeos Therapeutics, Inc. logo
    ITOS

    iTeos Therapeutics, Inc.

    Aug 29, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    146.2K shares-
  • iTeos Therapeutics, Inc. logo
    ITOS

    iTeos Therapeutics, Inc.

    Aug 29, 2025
    Disposition

    Stock Option (Right to Buy)

    Direct
    25.1K shares-
  • iTeos Therapeutics, Inc. logo
    ITOS

    iTeos Therapeutics, Inc.

    Jun 6, 2025
    Exercise
    Direct
    38.2K shares at avg. $4.30$164K
  • iTeos Therapeutics, Inc. logo
    ITOS

    iTeos Therapeutics, Inc.

    Jun 6, 2025
    Sale
    Direct
    38.2K shares at avg. $10.24$391K

1-10 of 18